[1] 付莎莉,付阿丹,王莉,等.内皮祖细胞DNA羟甲基化修饰在糖尿病血管并发症发病中的作用及其机制[J]. 现代医学,2021,49(1):1-5.
[2] CHO N H,SHAW J E,KARURANGA S,et al.IDF diabetes atlas:global estimates of diabetes prevalence for 2017 and projections for 2045[J]. Diabetes Res Clin Pract,2018,138:271-281.
[3] RODRÍGUEZ M L,PÉREZ S,MENA-MOLLÁ S,et al.Oxidative stress and microvascular alterations in diabetic retinopathy:future therapies[J]. Oxid Med Cell Longev,2019,2019:4940825.
[4] QIU A W,BIAN Z,MAO P A,et al.IL-17A exacerbates diabetic retinopathy by impairing Müller cell function via Act1 signaling[J]. Exp Mol Med,2016,48(12):e280.
[5] LINDSTROM S I,SIGURDARDOTTIR S,ZAPADKA T E,et al.Diabetes induces IL-17A-Act1-FADD-dependent retinal endothelial cell death and capillary degeneration[J]. J Diabetes Complications,2019,33(9):668-674.
[6] ZAPADKA T E,LINDSTROM S I,TAYLOR B E,et al.RORγt inhibitor-SR1001 halts retinal inflammation,capillary degeneration,and the progression of diabetic retinopathy[J]. Int J Mol Sci,2020,21(10):3547.
[7] ZHANG N N,KANG J S,LIU S S,et al.Flavanomarein inhibits high glucose-stimulated epithelial-mesenchymal transition in HK-2 cells via targeting spleen tyrosine kinase[J]. Sci Rep,2020,10(1):439.
[8] SU X,SUN Z H,REN Q,et al.The effect of spleen tyrosine kinase inhibitor R406 on diabetic retinopathy in experimental diabetic rats[J]. Int Ophthalmol,2020,40(9):2371-2383.
[9] MURAKAMI M,KAMIMURA D,HIRANO T.Pleiotropy and specificity:insights from the interleukin 6 family of cytokines[J]. Immunity,2019,50(4):812-831.
[10] 陈颖,陈礴,侯海文.血清LDL-C、NK-κB、IL-6水平变化与冠心病患者annexin A1相关性研究[J]. 现代医学,2020,48(2):213-216.
[11] PU L J,CHEN W,LIU Q H,et al.Relationship between miR-375 regulating Ndrg2/IL-6/STAT3 signaling pathway and diabetic retinopathy in rats[J]. Eur Rev Med Pharmacol Sci,2020,24(5):2189-2195.
[12] WANG Y,ZHAI W L,YANG Y W.Association between NDRG2/IL-6/STAT3 signaling pathway and diabetic retinopathy in rats[J]. Eur Rev Med Pharmacol Sci,2020,24(7):3476-3484.
[13] VALLE M L,DWORSHAK J,SHARMA A,et al.Inhibition of interleukin-6 trans-signaling prevents inflammation and endothelial barrier disruption in retinal endothelial cells[J]. Exp Eye Res,2019,178:27-36.
[14] KE B,CHEN Y,TU W,et al.Inhibition of HDAC6 activity in kidney diseases:a new perspective[J]. Mol Med,2018,24(1):33.
[15] YANG Q,LI S,ZHOU Z,et al.HDAC6 inhibitor Cay10603 inhibits high glucose-induced oxidative stress,inflammation and apoptosis in retinal pigment epithelial cells via regulating NF-κB and NLRP3 inflammasome pathway[J]. Gen Physiol Biophys,2020,39(2):169-177.
[16] YI E H,XU F,LI P,et al.Transactive response DNA binding protein of 43/histone deacetylase 6 axis alleviates H (2) O (2)-induced retinal ganglion cells injury through inhibiting apoptosis and autophagy[J]. J Cell Biochem,2019,120(3):4312-4320.
[17] LAM J D,OH D J,WONG L L,et al.Identification of RUNX1 as a mediator of aberrant retinal angiogenesis[J]. Diabetes,2017,66(7):1950-1956.
[18] ZOU W,ZHANG Z,LUO S,et al.p38 promoted retinal micro-angiogenesis through up-regulated RUNX1 expression in diabetic retinopathy[J]. Biosci Rep,2020,40(5):BSR20193256.
[19] CHEN Q,QIU F,ZHOU K,et al.Pathogenic role of microRNA-21 in diabetic retinopathy through downregulation of PPARα[J]. Diabetes,2017,66(6):1671-1682.
[20] LU J M,ZHANG Z Z,MA X,et al.Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy[J]. Exp Eye Res,2020,190:107886.
[21] LIU G,ZHOU S,LI X,et al.Inhibition of hsa_circ_0002570 suppresses high-glucose-induced angiogenesis and inflammation in retinal microvascular endothelial cells through miR-1243/angiomotin axis[J]. Cell Stress Chaperones,2020,25(5):767-777.
[22] SUN H,KANG X.hsa_circ_0041795 contributes to human retinal pigment epithelial cells (ARPE 19) injury induced by high glucose via sponging miR-646 and activating VEGFC[J]. Gene,2020,747:144654.
[23] LI Y,CHENG T,WAN C,et al.circRNA_0084043 contributes to the progression of diabetic retinopathy via sponging miR-140-3p and inducing TGFA gene expression in retinal pigment epithelial cells[J]. Gene,2020,747:144653.
[24] JIAN W,YU S,TANG M,et al.A combination of the main constituents of Fufang Xueshuantong capsules shows protective effects against streptozotocin-induced retinal lesions in rats[J]. J Ethnopharmacol,2016,182:50-56.
[25] HAO G M,LV T T,WU Y,et al.The Hippo signaling pathway:a potential therapeutic target is reversed by a Chinese patent drug in rats with diabetic retinopathy[J]. BMC Complement Altern Med,2017,17(1):187.
[26] XING W,SONG Y,LI H,et al.Fufang Xueshuantong protects retinal vascular endothelial cells from high glucose by targeting YAP[J]. Biomed Pharmacother,2019,120:109470.
[27] 姚牧笛,孙婷婷,蒋沁.血管内皮细胞在视网膜出芽式血管生成中的作用及其调控机制[J]. 国际眼科杂志,2020,20(2):251-254.
[28] 艾静,刘瑶,朱茂丽.脉络膜新生血管的靶分子治疗[J]. 现代医学,2007,35(3):243-246.
[29] LI R L,WANG J X,CHAI L J,et al.Xueshuantong for injection (lyophilized,) alleviates streptozotocin-induced diabetic retinopathy in rats[J]. Chin J Integr Med,2020,26(11):825-832.
[30] NADRI G,SAXENA S,MAHDI A A,et al.Serum vitamin D is a biomolecular biomarker for proliferative diabetic retinopathy[J]. Int J Retina Vitreous,2019,5:31.
[31] MERRIGAN S L,PARK B,ALI Z,et al.Calcitriol and non-calcemic vitamin D analogue,22-oxacalcitriol,attenuate developmental and pathological choroidal vasculature angiogenesis ex vivo and in vivo[J]. Oncotarget,2020,11(5):493-509.
[32] TOHARI A M,ALMARHOUN M,ALHASANI R H,et al.Protection by vitamin D against high-glucose-induced damage in retinal pigment epithelial cells[J]. Exp Cell Res,2020,392(1):112023.
[33] AFARID M,GHATTAVI N,JOHARI M.Serum levels of vitamin D in diabetic patients with and without retinopathy[J]. J Ophthalmic Vis Res,2020,15(2):172-177.
[34] YUAN J,ZHOU J B,ZHAO W,et al.Could vitamin D be associated with proliferative diabetic retinopathy? evidence from pooling studies[J]. Horm Metab Res,2019,51(11):729-734.
[35] POURHANIFEH M H,HOSSEINZADEH A,DEHDASHTIAN E,et al.Melatonin:new insights on its therapeutic properties in diabetic complications[J]. Diabetol Metab Syndr,2020,12:30.
[36] TU Y,ZHU M,WANG Z,et al.Melatonin inhibits Müller cell activation and pro-inflammatory cytokine production via upregulating the MEG3/miR-204/Sirt1 axis in experimental diabetic retinopathy[J]. J Cell Physiol,2020,235(11):8724-8735.
[37] MA Y,ZHAO Q,SHAO Y,et al.Melatonin inhibits the inflammation and apoptosis in rats with diabetic retinopathy via MAPK pathway[J]. Eur Rev Med Pharmacol Sci,2020,24(14):7545. |
